longbridge

TransCode Therapeutics

RNAZ
----

All Shareholders

Shareholder Type

  • Private companies85.26%
  • Public and others12.20%
  • Individuals & Insiders2.03%
  • Institutions0.52%

Major Shareholders

Major Shareholders Latest
Shareholder
DEFJ, LLC
83.48%14.13M75.25%+14.05M
Unleash Immuno Oncolytics, Inc.
1.77%300.00K--+300.00K
Elena Braci
1.10%186.24K--+186.24K
Daniel Katzman
0.92%155.61K--+155.61K
Sabby Management, LLC
0.25%41.60K4.29%+0
Yorkville Advisors Global LP
0.12%19.64K--+19.64K
Geode Capital Management, LLC
0.08%12.74K1.31%+0
Vanguard Capital Management, LLC
0.06%9.53K0.98%+0
UBS Asset Management AG
0.02%2.89K0.89%-5.41K
Thomas Tracy
<0.01%1.25K0.13%+0
Strategic Advisers LLC
<0.01%706.00--+706.00
Tower Research Capital Europe Limited
<0.01%677.000.02%+449.00
The Goldman Sachs Group, Inc.
<0.01%82.00<0.01%+0
Wells Fargo & Company
<0.01%55.00<0.01%+0
SBI Holdings, Inc.
<0.01%12.00<0.01%+0
Thomas FitzgeraldFormer CFO, Secretary, President, VP of Administration & Director
<0.01%3.00<0.01%+1.00
Philippe CalaisCEO & Executive Chairman of the Board
<0.01%2.00<0.01%+1.00
Erik MantingIndependent Director
0.00%0.000.00%+0
RBC Dominion Securities Inc.
0.00%0.00<0.01%-8.00
Magda MarquetIndependent Director
0.00%0.000.00%+0
© 2026 Longbridge｜Terms of ServicePrivacy Policy